Metabolic syndrome: Dysfunction in mTOR signaling is strongly linked to the symptoms of type 2 diabetes, including whole-body insulin resistance, hyperglycemia, and hyperlipidemia. This evidence concerns the gene MTOR and type 2 diabetes mellitus.